Advertisement

Topics

Marshall Edwards Company Profile

00:17 EDT 23rd September 2018 | BioPortfolio

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of oncology drugs - multiple signal transduction regulators (abbreviated as 'MSTRs') that reach to the heart of the cancer process.
The source of this new range of drugs is a family of chemicals, discovered by pharmaceutical company Novogen, that act against the fundamentals of the cancer process. Using this single technology platform, MEI is developing a number of drugs with novel actions against a range of different cancer types.
The first of these drugs - Phenoxodiol - has advanced to Phase II clinical studies.

Location

140 Wicks Road
North Ryde
New South Wales
2113
Australia

Contact

Phone: 61 2 8877 6196
Fax: 61 2 9878 8474
Email: meiinformation@marshalledwardsinc.com


News Articles [134 Associated News Articles listed on BioPortfolio]

Marshall University researchers identify inflammatory biomarkers in T cells

(Marshall University Joan C. Edwards School of Medicine ) The Marshall University School of Pharmacy, in collaboration with the Marshall University Joan C. Edwards School of Medicine Genomics Core, re...

Marshall University research offers insights into nervous system control of leg movements

(Marshall University Joan C. Edwards School of Medicine ) New research from a team at Marshall University Joan C. Edwards School of Medicine gives unexpected insights into how the nervous system contr...

Findings from Marshall University researcher reveal insights into brain circuitry

(Marshall University Joan C. Edwards School of Medicine ) New research from a team led by Marshall University scientist W. Christopher Risher, Ph.D., reveals novel molecular insights into how multiple...

Marshall School of Medicine research team defines possible anti-aging intervention

(Marshall University Joan C. Edwards School of Medicine ) New research demonstrates that Na/K-ATPase oxidant amplification loop (NAKL) is intimately involved in the aging process and may serve as a ta...

New study explores human T cell function under inflammatory conditions

The Marshall University School of Pharmacy, in collaboration with the Marshall University Joan C. Edwards School of MedicineGenomics Core, recently released a new study that explores human T cell func...

Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

European Patent Office Revokes Edwards Lifesciences '550 Patent MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it, along with sever...

Research Team Defines Possible Anti-Aging Intervention

NewsNew research demonstrates that the Na/K-ATPase oxidant amplification loop (NAKL) is intimately involved in the aging process.Contributed Author: 

MorphoSys: Shortseller Marshall Wace zieht sich etwas zurück

Martinsried (www.aktiencheck.de) - Leerverkäufer Marshall Wace verringert Netto-Leerverkaufsposition in MorphoSys-Aktien moderat: Die Leerverkäufer des Hedgefonds Marshall Wace LLP ziehen sich aus ....

PubMed Articles [27 Associated PubMed Articles listed on BioPortfolio]

Audiologic Manifestations of Marshall Syndrome.

Marshall syndrome is a genetic disorder caused by mutations in the COL11A1 gene. This syndrome is characterized by skeletal, ophthalmologic, craniofacial, and auditory abnormalities. Hearing loss is a...

Edwards SAPIEN Transcatheter Pulmonary Valve Implantation: Results From a French Registry.

The aim of this study was to describe and analyze data from patients treated in France with the Edwards SAPIEN transcatheter heart valve in the pulmonary position.

Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve.

The aim of this study was to determine factors affecting paravalvular leak (PVL) in transcatheter aortic valve replacement (TAVR) with the Edwards SAPIEN 3 (S3) valve in extremely large annuli.

Edwards Sapien XT® pulmonic valve compression after resuscitation and successful redilatation.

Despite the increasing use of percutaenous valves, little is known about valve performance after external chest compression. We report a case of a compressed pulmonary Edwards Sapien® XT valve after ...

The Edwards Sapien Valve in the Pulmonic Position: The Not-So-New Kid on the Block.

Clinical Trials [70 Associated Clinical Trials listed on BioPortfolio]

Edwards Cardioband European Post-Market Study, MiBAND

To demonstrate reduction of MR with durable performance and im-provements in functional status

EDWARDS INTUITY Valve System CADENCE-MIS Study

The study purpose is to compare the EDWARDS INTUITY valve system in a minimal invasive surgical approach (MIS) with any commercially available aortic bioprosthesis in standard full ster-no...

EDWARDS INTUITY Valve System CADENCE Study

The study purpose is to compare the EDWARDS INTUITY valve system with commercially available stented aortic bioprostheses, in patients requiring aortic valve replacement surgery with coron...

Multicenter Trial of Congenital Pulmonic Valve Dysfunction Studying the SAPIEN 3 THV With the Alterra Adaptive Prestent

To demonstrate the safety and functionality of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in patients with a dysf...

Medtronic's MOSAIC Bioprosthesis Versus Baxter Carpentier-Edwards SAV Porcine Valve

The study compares the clinical performance of the Mosaic valve with that of the Baxter valve (Carpentier-Edwards) which is widely used throughout the UK and is considered to be the "bench...

Companies [37 Associated Companies listed on BioPortfolio]

Marshall Edwards, Inc.

Marshall Edwards

Marshall Edwards, Inc. ('MEI') is a pharmaceutical company dedicated to the field of cancer therapy (oncology).MEI is developing a range of anti-cancer therapies that represents the next generation of...

Edwards Lifesciences Corporation

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its marke...

Edwards Ltd

Further information about Edwards can be found at www.edwardsvacuum.com.

Recombinant Capital

Recombinant Capital (Recap) is a San Francisco Bay Area-based consulting firm specializing in biotechnology alliances, earned alliance revenues, product sales, employment agreements, company informati...

More Information about "Marshall Edwards" on BioPortfolio

We have published hundreds of Marshall Edwards news stories on BioPortfolio along with dozens of Marshall Edwards Clinical Trials and PubMed Articles about Marshall Edwards for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Marshall Edwards Companies in our database. You can also find out about relevant Marshall Edwards Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record